5-(3-Aminoallyl)-2'-deoxyuridine-5'-triphosphate, labeled with ATTO 425, Triethylammonium salt
For research use only!
Shipping: shipped on blue ice
Storage Conditions: store at -20 °C
Short term exposure (up to 1 week cumulative) to ambient temperature possible.
Shelf Life: 12 months after date of delivery
Molecular Formula: C34H45N4O19P3 (free acid)
Molecular Weight: 906.66 g/mol (free acid)
Exact Mass: 906.16 g/mol (free acid)
Purity: ≥ 95 % (HPLC)
Form: green-yellow solution in water
Concentration: 1.0 mM - 1.1 mM
pH: 7.5 ±0.5
Spectroscopic Properties: λexc 439 nm, λem 485 nm, ε 45.0 L mmol-1 cm-1 (Tris-HCl pH 7.5)
Incorporation into DNA/cDNA by
- PCR with Taq polymerase in-house data
- Nick Translation with DNAse I/ DNA Polymerase I in-house data
Aminoallyl-dUTP-ATTO425 is recommended for direct enzymatic labeling of DNA/cDNA e.g. by PCR and Nick Translation. It is incorporated as substitute for its natural counterpart dTTP. The resulting Dye-labeled DNA/cDNA probes are ideally suited for fluorescence hybridization applications such as FISH or microarray-based gene expression profiling.Optimal substrate properties and thus labeling efficiency is ensured by an optimized linker attached to the C5 position of uridine.
Recommended Aminoallyl-dUTP-ATTO425/dTTP ratio for PCR and Nick Translation: 20-30% Aminoallyl-dUTP-ATTO425/ 80-70% dTTP (PCR), 30-50% Aminoallyl-dUTP-ATTO425/ 70-50% dTTP (Nick Translation)
Please note: Protect the Dye-labeled dUTP from exposure to light and carry out experimental procedures in low light conditions. The optimal final concentration of the Dye-labeled dUTP may very depending on the application and assay conditions. For optimal product yields and high incorporation rates an individual optimization of the Dye-labeled-dUTP/dTTP ratio is recommended.
Please click the black arrow on the right to expand the citation list. Click publication title for the full text.
Basinko et al. (2012) Clinical and molecular cytogenetic studies in ring chromosome 5: report of a child with congenital abnormalities.Eur. J. Med. Genet. 55 (2):112.